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ABSTRACT
Introduction: There is no consensus about what
constitutes the most appropriate patient-reported
outcome measurement (PROM) instrument for
measuring physical function in patients with rheumatic
hand conditions. Existing instruments lack
psychometric testing and vary in feasibility and their
psychometric qualities. We aim to develop a PROM
instrument to assess hand-related physical function in
rheumatic hand conditions.
Methods and analysis: We will perform a systematic
search to identify existing PROMs to rheumatic hand
conditions, and select items relevant for hand-related
physical function as well as those items from the
Patient Reported Outcomes Measurement Information
System (PROMIS) Physical Function (PF) item bank
that are relevant to patients with rheumatic hand
conditions. Selection will be based on consensus
among reviewers. Content validity of selected items will
be established through the use of focus groups. If
patients deem necessary, we will develop new items
based on the patients’ input. We will examine whether
it is valid to score all selected and developed items on
the same scale as the original items from the PROMIS
PF item bank. Our analyses will follow the methods
used for calibrating the original PROMIS PF item bank
in US samples, which were largely based on the
general PROMIS approach.
Ethics and dissemination: This study will be carried
out in accordance with the Helsinki Declaration. Ethics
approvals will be obtained where necessary, and
signed informed consent will be obtained from all
participants. We aim to disseminate the results of the
study through publication in international peer-
reviewed journals and at international conferences.
INTRODUCTION
Physical function is a concept covering the
‘ability to carry out activities that require phys-
ical actions ranging from self-care (activities of
daily living) to more complex activities that
necessitate a combination of skills, often
within a social context’ (http://www.
nihpromis.org/measures/domainframework1
28 August 2015). Many physical activities
involve skilled use of the hands. Patients with
two of the most common rheumatic condi-
tions, osteoarthritis (OA)1 and rheumatoid
arthritis (RA),2 frequently experience afﬂic-
tion of the joints of the hands and surround-
ing tissues consisting of pain and swelling
caused by underlying pathology/disease activ-
ity. As a consequence, hand function is prone
to deterioration, causing decreased physical
function when patients perform activities
requiring their hands.3 Therefore, physical
function is both one of the core domains to be
measured and reported in all clinical trials in
hand OA4 5 and a recommended core
outcome for RA.6
At the Outcome Measures in Rheumatology
(OMERACT) meeting in May 2014, a
Strengths and limitations of this study
▪ The aim points to fulfil a need for a new patient-
reported outcome measurement (PROM) to
assess hand function.
▪ The proposed methodology follows the best
practice standards for developing PROMs.
▪ The use of Computer Adaptive Testing (CAT)
potentially reduces patient burden in terms of
time to fill out questionnaires.
▪ The domain of the outcome measurement instru-
ment is limited to function, based on the
assumption that function is a pivotal construct
that also relates to other aspects of a health con-
dition (eg, pain).The patient population is limited
to osteoarthritis and rheumatoid arthritis with
hand involvement.
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preliminary core outcome set for hand OA was proposed,
which included physical function.5 From discussions at the
meeting, it was clear that consensus is needed about what
constitutes the most appropriate patient-reported
outcome measurement (PROM) instrument for measur-
ing physical function in patients with rheumatic hand con-
ditions.7 8 Both disease-speciﬁc and generic instruments
were discussed; of the potential instruments mentioned,
the Australian Canadian Osteoarthritis Hand Index
(AUSCAN9) and the Functional Index for Hand
Osteoarthritis (FIHOA10) were considered to be of best
quality. However, both these instruments fail to fully
comply with the OMERACT ﬁlter V.2.0,11 which comprises
the quality criteria discrimination, truth and feasibility.
The AUSCAN does not comply with the feasibility criter-
ion because it is copyrighted, and the FIHOA does not
comply with the truth criterion (validity) because patients
present at the OMERACT meeting considered it outdated.
The Disabilities of the Arm, Shoulder, and Hand
(DASH12), the Michigan Hand Questionnaire (MHQ13),
and the Patient-Rated Wrist Hand Evaluation (PRWHE14)
were recommended for further testing of psychometric
qualities.5 This recommendation is supported by a review
concluding that existing instruments measuring physical
function in patients with rheumatic hand conditions lack
psychometric testing and vary in feasibility and their psy-
chometric qualities, that is, validity, reliability, responsive-
ness and interpretability.15
Owing to the limitations of the instruments reviewed
above, the Patient Reported Outcomes Measurement
Information System (PROMIS) Physical Function (PF)
item bank was suggested as a potential alternative (see
Competing interests statement). The PROMIS PF item
bank was developed using item response theory (IRT)
methods16 and can be administered in the form of dif-
ferent static questionnaires (short forms) or through
Computer Adaptive Testing (CAT), where, after a ﬁxed
starting question, the computer selects the next question
(s) based on the answer(s) to the previous question(s)
until a reliable score is achieved. Although the PROMIS
PF item bank is a generic instrument to assess physical
function, two studies17 18 found that the upper extremity
part of the PROMIS PF CAT instrument compared
favourably with the body region-speciﬁc PROM instru-
ment DASH in orthopaedic outpatient populations.
Previously, new items to assess ﬂoor and ceiling physical
function have been developed in order to supplement
the existing PROMIS PF item bank.19 20
Using a PROMIS CAT would yield several advantages
to conventional questionnaires, the most important ones
being comparability of scores across populations
(because all PROMIS instruments are scored on a
common metric),16 and a decreased administrative
burden for patients; typically with CAT, only 5–7 items
need to be completed to obtain a reliable score.21 To
optimise the content validity of the PROMIS PF item
bank for patients with rheumatic hand conditions, our
ﬁrst aim is to select those items from the PROMIS PF
item bank that are relevant for patients with rheumatic
hand conditions, select additional items from other
existing PROMs, and develop new items if patients deem
them necessary. If any additional or new items are
needed, our second aim is to examine whether it is valid
to score these items on the same scale as the original
items from the PROMIS PF item bank. If these items
can be scored on the common PROMIS PF metric, they
can be added to the PROMIS PF item bank. The total
set of PF items relevant for patients with hand problems
can then be used as a hand-speciﬁc PF short form or a
hand-speciﬁc PF CAT. Scores on these instruments will
be comparable to scores from any (patient) population
that completed any of the other PROMIS PF item
subsets. If the new hand items cannot be scored on the
common PROMIS PF metric, the total set of PF items
can inform the development of a new PROM.
To measure physical function, it seems reasonable to
develop an instrument that is suitable for patients across
different types of rheumatic hand conditions, as patients
with hand OA and RA experience similar functional
problems. This goal becomes evident when comparing
the brief International Classiﬁcation of Functioning,
Disability and Health (ICF) Core Sets for Hand
Conditions,22 OA23 and RA,24 which share the following
domains: (1) sensation of pain, (2) mobility of joint
functions, (3) muscle power functions, (4) structure of
upper extremity and (5) hand and arm use. However, it
is not the intention of this project to cover all of the
above. The domain of the outcome measurement instru-
ment is limited to function in order to adhere to the
assumption of unidimensionality. Such an instrument
may also be suitable for patients with other hand condi-
tions, although this possibility has to be determined in
future studies.
OBJECTIVES
We aim to develop a PROM to assess hand-related phys-
ical function in rheumatic hand conditions.
METHODS
The target population consists of adult patients with
rheumatic conditions (deﬁned as OA according to the
American College of Rheumatology (ACR) criteria25 or
as RA according to the ACR/European League Against
Rheumatism (EULAR) criteria)26 affecting their hands.
The instrument should be useful for discriminative and
evaluative purposes. It was decided to focus only on
these conditions, because they are the most common
diagnoses with hand involvement within rheumatology.27
Speciﬁc steps of this study are to:
1. Perform a systematic search to identify existing
PROMs to rheumatic hand conditions, and select
items relevant for hand-related physical function.
Selection will be based on consensus among
reviewers.
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2. Select items from the PROMIS PF item bank relevant
to patients with rheumatic hand conditions. Selection
will be based on consensus among reviewers.
3. Ensure the content validity of the selected items by
discussing the items in focus groups with patients
with hand OA or RA.
4. Develop new items in case of content under-
representation. The items will be based on patients’
input.
5. Pilot test the selected items to evaluate the compre-
hensibility and comprehensiveness of the items.
6. Calibrate and validate any additional and new items
to examine whether it is valid to score them on the
same scale as the original items from the PROMIS PF
item bank.
Identifying relevant items
Relevant items will be selected from the PROMIS PF
item bank by two reviewers, working independently, who
have clinical experience in addressing physical function
in patients with rheumatic hand conditions. Relevant
items are deﬁned as items concerning hand-related
physical function. The ﬁnal selection will be based on
consensus between the two reviewers (or with help from
a third reviewer if necessary). The item bank has already
been translated into Danish, German and
Dutch-Flemish (using standardised methodology and
approved by the PROMIS Statistical Center).
A systematic search will be performed in PubMed,
from database inception to identify PROMs for patients
with hand problems. The search strategy from PubMed
is shown in table 1. The website http://www.
rehabmeasures.org will be searched for relevant PROMs.
Abstracts will be screened by one reviewer (LK), and
the names of relevant PROMs will be extracted. Full
copies of relevant PROMs will be obtained. Items rele-
vant to measuring physical function in patients with
rheumatic hand conditions will be extracted independ-
ently by two reviewers with experience in addressing
physical function in patients with rheumatic hand condi-
tions, and added to the list of items selected from the
PROMIS PF item bank. Duplicates will be removed from
the list by the two reviewers together; in case of a dupli-
cate with a PROMIS item, the PROMIS item will be
retained. If necessary, items will be translated by the
authors into Danish, German and Dutch-Flemish. A
formal forward–backward translation procedure is not
considered necessary at this stage of the project.
Content validity of the item pool
To develop a relevant and comprehensive instrument,
we will take a qualitative approach involving the target
population in focus groups to validate the item pool
developed from the PROMIS PF item bank and from
the literature, and expand it if necessary.
A purposive sample of adults with hand OA and RA
will be recruited through participating clinics and hospi-
tals: Rheumatology, Ghent University Hospital and
University Hospitals Leuven, Belgium; the Department
of Rheumatology, Leiden University Medical Center,
Leiden, the Netherlands; Department of Rheumatology,
Diakonhjemmet Hospital, Oslo, Norway; and the OA
outpatient clinic at the Department of Rheumatology at
Bispebjerg and Frederiksberg Hospital, Denmark.
Patients eligible to participate must have a clinical
diagnosis of OA according to the ACR criteria25 or RA
according to the ACR/EULAR criteria,26 affecting their
hands. Patient with hand problems related to non-
rheumatic disorders will not be considered eligible for
inclusion. The aim is to include a variety of patients in
terms of age, gender (distribution similar to the back-
ground population), diagnosis, disease severity (patient
reported through the question: How severe is your
disease, on a scale from 0 to 10 where 0 is not severe at
all and 10 is the most severe you can imagine?), disease
duration, need of aids, current pain on the Numerical
Pain Rating Scale, education, ethnicity and occupation.
Patients who are unable to speak or write the language
at issue, or who do not understand information about
the project, are not eligible. Patients will receive oral
and written information prior to participating and will
provide signed, informed consent before enrolling in
the project.
To involve patients in identifying relevant issues, focus
groups will be conducted separately at study sites in four
countries (Belgium, the Netherlands, Norway and
Denmark), so patients can use their native language. We
anticipate conducting one focus group at each study
site, each with 6–8 participants, yielding a total of three
focus groups with 24–32 participants. Each focus group
will be of a planned duration of 4–5 hours, including
breaks with refreshments. If differences are found
among the focus groups, additional focus groups will be
conducted at one of the sites until saturation has been
reached. At each focus group, one skilled or trained
moderator and one assistant will be present.
During the focus groups, the following steps are per-
formed, adapted from the concept mapping approach:29
(1) participants are asked to identify “…all the things
that your hand condition limits you in doing” individu-
ally, generating statements; (2) a common list of state-
ments for the group is made, consisting of input from
all participants; (3) the participants are presented with
the item pool extracted from the PROMIS PF bank and
other existing PROMs; (4) the group will discuss items
that are included in the item pool but not mentioned by
patients, as well as statements mentioned by patients
who are not included in the item pool; a ﬁnal item pool
will be developed; (5) each participant will rate the rele-
vance of all items on the list, on a ﬁve-point scale: 1:
‘not relevant to my condition at all’; 2: ‘rarely relevant to
my condition’; 3: ‘sometimes relevant with my condi-
tion’; 4: ‘very relevant with my condition’ and 5: ‘essen-
tial (it would not be my condition without it)’. The
mean and median ratings of statement importance are
calculated for all items in order to produce a rank order
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Table 1 Search strategy
Search Filter Query
#6 Exclusion filter #5 NOT (‘addresses’[Publication Type] OR ‘biography’[Publication Type] OR ‘case reports’[Publication Type] OR
‘comment’[Publication Type] OR ‘directory’[Publication Type] OR ‘editorial’[Publication Type] OR ‘festschrift’[Publication
Type] OR ‘interview’[Publication Type] OR ‘lectures’[Publication Type] OR ‘legal cases’[Publication Type] OR
‘legislation’[Publication Type] OR ‘letter’[Publication Type] OR ‘news’[Publication Type] OR ‘newspaper article’[Publication
Type] OR ‘patient education handout’[Publication Type] OR ‘popular works’[Publication Type] OR ‘congresses’[Publication
Type] OR ‘consensus development conference’[Publication Type] OR ‘consensus development conference,
nih’[Publication Type] OR ‘practice guideline’[Publication Type]) NOT (‘animals’[MeSH Terms] NOT ‘humans’[MeSH
Terms])
#5 #1 AND #2 AND #3 AND #4
#4 Function Function*[tiab] OR *function[tiab] OR activit*[tiab] OR disability[tiab]
#3 PROM filter Search ((HR-PRO[tiab] OR HRPRO[tiab] OR HRQL[tiab] OR HRQoL[tiab] OR QL[tiab] OR QoL[tiab] OR quality of life[tw]
OR life quality[tw] OR health index*[tiab] OR health indices[tiab] OR health profile*[tiab] OR health status[tw] OR ((patient
[tiab] OR self[tiab] OR child[tiab] OR parent[tiab] OR carer[tiab] OR proxy[tiab]) AND ((report[tiab] OR reported[tiab] OR
reporting[tiab]) OR (rated[tiab] OR rating[tiab] OR ratings[tiab]) OR based[tiab] OR (assessed[tiab] OR assessment[tiab]
OR assessments[tiab]))) OR ((disability[tiab] OR function[tiab] OR functional[tiab] OR functions[tiab] OR subjective[tiab]
OR utility[tiab] OR utilities[tiab] OR wellbeing[tiab] OR well being[tiab]) AND (index[tiab] OR indices[tiab] OR instrument
[tiab] OR instruments[tiab] OR measure[tiab] OR measures[tiab] OR questionnaire[tiab] OR questionnaires[tiab] OR profile
[tiab] OR profiles[tiab] OR scale[tiab] OR scales[tiab] OR score[tiab] OR scores[tiab] OR status[tiab] OR survey[tiab] OR
surveys[tiab]))))
#2 Precise search filter on measurement
properties28
Search instrumentation[sh] OR ‘Validation Studies’[pt] OR ‘reproducibility of results’[MeSH Terms] OR reproducib*[tiab]
OR ‘psychometrics’[MeSH] OR psychometr*[tiab] OR clinimetr*[tiab] OR clinometr*[tiab] OR ‘observer variation’[MeSH]
OR ‘observer variation’[tiab] OR ‘discriminant analysis’[MeSH] OR reliab*[tiab] OR valid*[tiab] OR coefficient[tiab] OR
‘internal consistency’[tiab] OR (cronbach*[tiab] AND (alpha[tiab] OR alphas[tiab])) OR ‘item correlation’[tiab] OR ‘item
correlations’[tiab] OR ‘item selection’[tiab] OR ‘item selections’[tiab] OR ‘item reduction’[tiab] OR ‘item reductions’[tiab] OR
agreement[tiab] OR precision[tiab] OR imprecision[tiab] OR ‘precise values’[tiab] OR test-retest[tiab] OR (test[tiab] AND
retest[tiab]) OR (reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR stability[tiab] OR interrater[tiab] OR inter-rater[tiab] OR
intrarater[tiab] OR intra-rater[tiab] OR intertester[tiab] OR inter-tester[tiab] OR intratester[tiab] OR intra-tester[tiab] OR
interobserver[tiab] OR inter-observer[tiab] OR intraobserver[tiab] OR intra-observer[tiab] OR intertechnician[tiab] OR
inter-technician[tiab] OR intratechnician[tiab] OR intra-technician[tiab] OR interexaminer[tiab] OR inter-examiner[tiab] OR
intraexaminer[tiab] OR intra-examiner[tiab] OR interassay[tiab] OR inter-assay[tiab] OR intraassay[tiab] OR intra-assay
[tiab] OR interindividual[tiab] OR inter-individual[tiab] OR intraindividual[tiab] OR intra-individual[tiab] OR interparticipant
[tiab] OR inter-participant[tiab] OR intraparticipant[tiab] OR intra-participant[tiab] OR kappa[tiab] OR kappa’s[tiab] OR
kappas[tiab] OR repeatab*[tiab] OR ((replicab*[tiab] OR repeated[tiab]) AND (measure[tiab] OR measures[tiab] OR
findings[tiab] OR result[tiab] OR results[tiab] OR test[tiab] OR tests[tiab])) OR generaliza*[tiab] OR generalisa*[tiab] OR
concordance[tiab] OR (intraclass[tiab] AND correlation*[tiab]) OR discriminative[tiab] OR ‘known group’[tiab] OR ‘factor
analysis’[tiab] OR ‘factor analyses’[tiab] OR dimensionality[tiab] OR subscale*[tiab] OR ‘multitrait scaling analysis’[tiab]
OR ‘multitrait scaling analyses’[tiab] OR ‘item discriminant’[tiab] OR ‘interscale correlation’[tiab] OR ‘interscale
correlations’[tiab] OR ((error[tiab] OR errors[tiab]) AND (measure*[tiab] OR correlat*[tiab] OR evaluat*[tiab] OR accuracy
[tiab] OR accurate[tiab] OR precision[tiab] OR mean[tiab])) OR ‘individual variability’[tiab] OR ‘variability analysis’[tiab] OR
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to guide future selection of items for instrument valid-
ation, that is, patients’ ratings of item relevance will be
considered in case the results of the IRT analyses suggest
that two or more items cover the same level of difﬁculty.
Further, participants will be asked to provide demo-
graphic data including age, gender, diagnosis, disease
severity, disease duration, need of aids, current pain on
the Numerical Pain Rating Scale, education, occupation
and ethnicity in order to describe our study population
and estimate the transferability of the results. Further,
self-reports on height, weight, subset of disease (which
areas are affected), comorbidities and affection of other
joints are gathered.
Transformation to items and translation
For each new statement from the ﬁnal item pool, an
item is formulated in English. The newly generated
items are framed to ﬁt the existing items from the
PROMIS PF item bank (eg, “Are you able to…”) Likewise,
the items selected from existing PROMs are reframed to
ﬁt the existing items from the PROMIS PF item bank.
The newly framed items and the reframed items from
the ﬁnal item pool are then (back) translated into
German, Dutch-Flemish, Norwegian and Danish using
standardised methodology approved by the PROMIS
Statistical Center. This process is guided by the original
statements produced in the local focus groups when pos-
sible. The ﬁnal item pool constitutes the tentative item
bank (in four languages: English, German,
Dutch-Flemish and Danish) for hand-related physical
function for rheumatic conditions involving hands.
PILOT TESTING
Pilot testing of the tentative item bank for hand-related
physical function is performed to establish comprehensi-
bility and comprehensiveness of the items. Participants
will be recruited from the involved study sites. At each
site, a stratiﬁed sample of about 10 patients with a
rheumatic hand condition will be recruited, varying in
terms of age, gender, diagnosis, disease severity, disease
duration, need of aids, current pain on the Numerical
Pain Rating Scale, education and occupation.
A qualitative cognitive interview method will be used,
such as a think aloud method, Three Step Test inter-
views, or cognitive debrieﬁng to evaluate the compre-
hensibility and comprehensiveness of the items. Skilled
or trained interviewers will be used. The interviews will
be recorded, and two persons (LK and a local
researcher) will be involved in the analyses. Suggested
modiﬁcations to the items will be discussed in the
project group. If major changes are made, a new pilot
test will be performed.
CALIBRATION AND VALIDATION OF THE ITEM BANK
In each participating country, we intend to recruit a
sample of 200 patients (depending on funding) to
obtain a sample of at least 800 patients in total, following
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the recommendations of the European Organisation for
Research and Treatment of Cancer (EORTC) Quality of
Life Group which suggested ‘a minimum of 200 respon-
dents per group as a requirement for logistic regression
Differential Item Functioning (DIF) analyses’.30 Since
we are aiming at investigating language DIF using
ordinal logistic regression, n=200 per country is a rea-
sonable number. Patients eligible for participation must
have a clinical diagnosis of OA according to the ACR cri-
teria25 or RA according to the ACR/EULAR criteria26
affecting their hands. Patients who are unable to speak
or write the language at issue, or who do not understand
information about the project, are not eligible. Patients
will receive oral and written information prior to partici-
pating and will provide signed, informed consent before
enrolling in the project. For participating countries
where Ethics Committee approval is required for this
type of project, approval will be obtained before project
start.
Patients will be invited by email or letter to ﬁll in a
web-based (digital) or paper-and-pencil (paper) ques-
tionnaire. Both options are available as it has been
shown that the results from paper administration and
electronic administration of questionnaires are compar-
able.31–34 For the digital questionnaire, patients will
receive personal login codes. The questionnaire will
include the full item bank developed under objectives
1–5. Participants will be asked to provide demographic
data including age, gender, diagnosis, disease severity,
disease duration, need of aids, education, occupation
and the PROMIS Global Health item bank (further 10
items, including an item on current pain on the
Numerical Pain Rating Scale), in order to describe our
study population and estimate the transferability of the
results. Two further PROMs, the FIHOA and the DASH,
were selected for evaluating construct validity based on
evidence of their measurement properties from existing
systematic reviews of PROMs.
Calibration analyses will be conducted at the
Department of Psychosomatic Medicine at Charité—
Universitätsmedizin Berlin, Germany. The analyses will
follow the methods used for calibrating the original
PROMIS PF item bank in US samples,35 which were
largely based on the general PROMIS approach.36
Unidimensionality will be examined using conﬁrmatory
factor analyses (CFA). Since previous studies suggested a
potential two-factor solution,35 the assumed unidimen-
sional factor solution will be compared with an alterna-
tive two factorial model to investigate if the new items
measuring hand function can be scaled on the same
metric as the remaining items of the entire PF item
bank. The two-factor solution is deﬁned as hand-related
and ﬁnger-related activities (ﬁne motor actions), as
opposed to the rest of the item bank (gross motor
actions). Preliminary model ﬁt will be evaluated based
on commonly applied ﬁt indices; items with factor load-
ings <0.60 will be considered candidates for exclusion.
To evaluate model ﬁt, the following ﬁt indices will be
examined: Comparative Fit Index (CFI), Tucker Lewis
Index (TLI), Root Means Square Error of
Approximation (RMSEA) and Standardised Root Mean
Residuals (SRMR). The criteria for unidimensionality
include CFI>0.95, TLI>0.95, RMSEA<0.06 and
SRMR<0.08.37 38 However, since common ﬁt statistics
may be misleading in dimensionality assessment of
patient-reported outcomes (PROs),39 exploratory-based
techniques, such as explained common variance (ECV),
were recently suggested as being most appropriate to
test for unidimensionality.40 Therefore, we will estimate
an additional exploratory bifactor model to determine
the ECV as an indicator for unidimensionality
(ECV>0.60).40 Local dependence will be evaluated by
examining the residual correlation matrix resulting from
the single factor CFA; a residual correlation of a pair of
items >0.25 will indicate local dependence. In such
cases, the item showing a higher accumulated residual
correlation with the remaining items will be considered
for exclusion.
Monotonicity of the items will be evaluated by ﬁtting a
non-parametric IRT model using Mokken scaling36 and
visual inspection of resulting item characteristic curves.
After IRT assumptions are evaluated, including the
aforementioned monotonicity check, a Graded
Response Model (GRM) will be ﬁtted to the data to cali-
brate the item parameters.41 To assess the ﬁt of the
GRM and the degree to which possible misﬁt affects the
IRT model, S-X2 statistic will be used. Items that show
S-X2 p values <0.001 will indicate a poor ﬁt. DIF for age
(median split), gender and language will be evaluated
using ordinal logistic regression models as described by
Nagelkerke.42 An R2 change of ΔR2>0.03 will indicate
noticeable DIF. Based on the GRM, item information
functions will be calculated for each item, which will
determine the speciﬁc contribution of an item to the
precision of the entire item bank on a given level of
physical function. Summarising information functions
(IIFs) will enable estimation of the SEs (as a parameter
of reliability) across the score range of the entire item
bank. If DIF is not indicated for English language
(USA) versus other languages (European countries),
IRT θ scores will be transformed into T-scores anchored
on the US item parameters of the PROMIS PF item
bank. Construct validity will be evaluated by correlating
the T-scores of the item bank to the scores on the legacy
instruments. A correlation of >0.50 is expected.43
ETHICS AND DISSEMINATION
PROs are frequently deﬁned as ‘any report of the status
of a patient’s health condition that comes directly from
the patient, without interpretation of the patient’s
response by a clinician or anyone else’. We anticipate
that the development of a PROM to assess hand-related
physical function in rheumatic hand conditions will
provide researchers and clinicians with an efﬁcient, reli-
able and valid assessment tool. Our ultimate goal will be
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to develop a PROM for use in clinical trials where PRO
end points are used to support product labelling claims
—an instrument that can subsequently be applied in
clinical practice as well. The results of this global initia-
tive will be discussed and thus disseminated at EULAR,
Osteoarthritis Research Society International (OARSI),
ACR and hopefully be presented as a workshop at the
next OMERACT meeting (2018).
Limitations of this project could be:
▸ The domain of the outcome measurement instru-
ment is limited to function, based on the assumption
that function is a pivotal construct that also relates to
other aspects of a health condition (eg, pain).
▸ The patient population is limited to OA and RA with
hand involvement.
▸ The risk that the newly developed hand-related items
are not measuring the same (unidimensional) PF
construct as deﬁned by the original PROMIS PF con-
struct. Consequently, if this is the case, we will not be
able to calibrate these items on the PROMIS metric.
The methodology that this project is based on repre-
sents the current best practice44 within development of a
patient-reported questionnaire of hand physical function
for use in common rheumatic conditions. It is antici-
pated that there is a clinical need as there is no consen-
sus about the best choice of hand PROM; for example,
AUSCAN9 and FIHOA,10 both developed for hand OA,
are the most frequently used and respected, but the
former is associated with licence use, restricting its feasi-
bility and widespread application, and some of the items
in the latter have been criticised lately for not being con-
temporary. For RA, Michigan hand questionnaire13 and
DASH12 are more frequently used, but need further psy-
chometric evaluation.
Other advantages to the approach taken in this project
will be the linking to the existing PROMIS programme
and using the CAT technology where only a subset of
items are needed compared with paper form PROMs.
This potentially reduces the burden on patients.
This study will be carried out in accordance with the
Declaration of Helsinki. Ethics approvals will be
obtained where necessary. Signed informed consent will
be obtained from all participants. We aim to disseminate
the results of the study through publication in inter-
national peer-reviewed journals and at international
conferences.
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